Recombinant interferon-α-2a for treatment of chronic hepatitis C: Results of a multicenter randomized controlled dose study

Liver

Volumn 17, Issue 2, 1997, Pages 88-92

  Imai, Y ^a,b,k   Kawata, S ^a   Tamura, S ^a   Ito, N ^a   Seki, K ^c,d,l   Nishiuchi, M ^c   Shinji, Y ^c   Kiriyama, K ^e,m   Himeno, S ^e,m   Minami, Y ^f,n   Kashihara, T ^g   Kawakami, F ^g   Maeda, H ^h   Yabuuchi, I ^i,o   Nishioka, M ^i,o   Shirai, Y ^j,p   Fukuda, K ^a   Kiso, S ^a   Ito, T ^a   Igura, T ^a   Doi, Y ^a   Matsuzawa, Y ^a   more..

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Ikeda Municipal Hospital   (Japan)

^c Hyogo Prefectural Nishinomiya Hospital   (Japan)

^d Kawanishi City Hospital   (Japan)

^e Ashiya City Hospital   (Japan)

^f Osaka Central Hospital   (Japan)

^g Itami City Hospital   (Japan)

^h TOYONAKA MUNICIPAL HOSPITAL   (Japan)

ⁱ Otemae Hospital   (Japan)

^j Izumisano Municipal Hospital   (Japan)

^k Ikeda Municipal Hospital   (Japan)

^l Kawanishi City Hospital   (Japan)

^m Ashiya Municipal hospital   (Japan)

ⁿ Osaka Central Hospital   (Japan)

^o Otemae Hospital   (Japan)

^p Izumisano Municipal Hospital   (Japan)

more..

Author keywords

Chronic hepatitis C; Multivariate regression analysis; Platelet; Recombinant interferon 2a; Serum HCV RNA level

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; THROMBOCYTE COUNT;

EID: 8244221017     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb00786.x     Document Type: Article

References (21)

1. HOOFNAGLE J H, MULLEN K D, JONES D B, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha IFN: a preliminary report. N Engl J Med 1986: 315. 1575-1578.
2. DAVIS G L, BALART L A, SCHIFF E R, et al Treatment of chronic hepatitis C with recombinant IFN alpha: a multicenter randomized, controlled trial. N Engl J Med 1989: 321: 1501-1506.
3. DI BISCEGLIE A M, MARTIN P, KASSIANIDES C, et al. Recombinant Interferon alpha therapy for chronic hepatitis C: randomized, double-blind, placebo-controlled trial. N Engl J Med 1989: 321: 1506-1510.
4. MARCELLIN P, BOYER N, GIOSTRA E, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis, a multicenter randomized controlled trial from France. Hepatology 1991: 101. 497-502.
5. SHINDO M, DI BISCEGLIE A M, CHEUNG L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991: 115: 700-704.
6. CHEMELLO L, BONETTI P, CAVALLETTO L, et al Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995: 22: 700-706.
7. KASAHARA A, HAYASHI N, HIRAMATSU N, et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995: 21: 291-297.
8. LIN R, ROACH E, ZIMMERMANN M, et al. Interferon alpha-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rate. Results of the first multicentre Australian trial. J Hepatol 1995: 23: 487-496.
9. SÁEZ-ROYUELA F, PORRES J C, MORENO A, et al. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology 1991: 13: 327-331.
10. IINO S, HINO K, KUROKI T, et al. Treatment of chronic hepatitis C with high-dose interferon α-2b. A multicenter study. Dig Dis Sci 1993: 38: 612-618.
11. SERFATY L, GIRAL P, LORIAL A, et al Factors predictive of interferon in patients with chronic hepatitis C. J. Hepatology 1994: 21: 12-17.
12. HAYASHI J, OHMIYA M, KISHIHARA Y, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 1994: 12: 2151-2156.
13. YAMADA G, TAKANI M, KISHI F, et al. Efficacy of interferon alpha therapy in chronic hepatitis C virus RNA level. Hepatology 1995: 22: 1351-1354.
14. LAU J Y N, DAVIS G L, KNIFFEN J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993: 341: 1501-1505.
15. KANAI K, KAKO M, OKAMOTO H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992: 339: 1543.
16. YOSHIOKA K, KAKAMU S, WAKITA T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992: 16: 293-299.
17. KATO N, YOKOSUKA O, OMATA M, et al. Detection of hepatitis C virus ribonucleic acid in serum by amplification with polymerase chain reaction. J Clin Invest 1990: 86: 1764-1767.
18. OZEKI T, HIKIJI K, FUNAKOSHI K, TSUTSUMI Y, YOSHIDA A. Infection of chang cells with hepatitis C virus using hepatic biopsy specimens from patients with chronic hepatitis (type C). Int J Exp Path 1992. 73: 1-8.
19. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers' application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-679.
20. PICCIOTTO A, CALLAEA F, VARAGONA G, et al. Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses. Liver 1995: 15: 20-24.
21. MARTIN T, SOMBERG K, COHEN R L, et al. Thrombopoietin may play a major role in thrombocytopenia of cirrhosis. Gastroenterology 1996: 110(suppl.): A1259.